Sanofi should hear from the FDA in September about its application for Sarclisa as a first-line therapy for multiple myeloma after the US regulator gave it a priority review. The French pharma group ...

But he might just as easily be describing the quiet conviction — held now by a growing number of founders, developers and ...

As elsewhere on the Milan catwalk, there were suits galore, and very elegant ones too. A trouser suit in black wool, an above ...